fbpx Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial |ARAB AMERICAN UNIVERSITY
Contact information for Technical Support and Student Assistance ... Click here

Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial

Authors: 
Osama Sawalmeh, Shaheed Moala, Zakaria Hamdan, Huda Masri,Khubaib Ayoub, Emad Khazneh, Mujahed Shraim
ISSN: 
179.61.163.46
Journal Name: 
International Journal of Nephrology and Renovascular Disease
Volume: 
2018
Issue: 
11
Pages From: 
25
To: 
32
Date: 
Monday, January 15, 2018
Keywords: 
end-stage kidney disease, hemodialysis, alfacalcidol, parathyroid hormone, hyperparathyroidism, randomized controlled trials, pulse therapy